TABLE 2 .
Module ID | Module title | r | q value |
---|---|---|---|
LI.M200 | Antigen processing and presentation | 0.25 | 3.86E−16 |
LI.M95.0 | Enriched in antigen presentation (II) | 0.22 | 3.43E−14 |
DC.M8.83 | Immune responses | 0.22 | 1.68E−10 |
LI.M71 | Enriched in antigen presentation (I) | 0.15 | 9.94E−08 |
LI.M37.0 | Immune activation—generic cluster | −0.07 | 5.50E−06 |
LI.M17.3 | Hox cluster IV | −0.25 | 9.40E−06 |
LI.S2 | B cell surface signature | 0.07 | 1.06E−05 |
LI.M146 | MHC-TLR7-TLR8 cluster | 0.09 | 0.0002 |
LI.M168 | Enriched in dendritic cells | −0.28 | 0.001 |
LI.M5.0 | Regulation of antigen presentation and immune response | 0.09 | 0.002 |
LI.M17.1 | Hox cluster II | −0.03 | 0.003 |
LI.M17.0 | Hox cluster I | −0.19 | 0.003 |
LI.M96 | Hox cluster V | −0.03 | 0.004 |
DC.M5.15 | Neutrophils | −0.11 | 0.005 |
LI.M24 | Cell activation (IL-15, IL-23, TNF) | −0.18 | 0.009 |
LI.M74 | Transcriptional targets of glucocorticoid receptor | −0.12 | 0.02 |
DC.M4.13 | Inflammation | −0.18 | 0.02 |
LI.M160 | Leukocyte differentiation | −0.09 | 0.02 |
LI.M37.1 | Enriched in neutrophils (I) | −0.26 | 0.03 |
LI.M75 | Antiviral IFN signature | −0.14 | 0.03 |
DC.M4.2 | Inflammation | −0.22 | 0.03 |
LI.M112.0 | Complement activation (I) | −0.11 | 0.04 |
DC.M3.2 | Inflammation | −0.18 | 0.04 |
LI.M57 | Immunoregulation—monocytes, T and B cells | −0.21 | 0.04 |
“Module ID” refers to the original publication, where the prefix “LI” refers to BTMs according to Li et al. (17), and the prefix “DC” refers to BTMs according to Chaussabel et al. (18). Only modules with a functional annotation are shown. r is the average correlation coefficient in the module, and the q value is the P value in a randomization test corrected for multiple testing. IFN, interferon; IL, interleukin; TNF, tumor necrosis factor.